Iris Walraven

1.5k total citations
67 papers, 939 citations indexed

About

Iris Walraven is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Iris Walraven has authored 67 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Iris Walraven's work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (12 papers) and Advanced Radiotherapy Techniques (9 papers). Iris Walraven is often cited by papers focused on Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (12 papers) and Advanced Radiotherapy Techniques (9 papers). Iris Walraven collaborates with scholars based in Netherlands, United States and Germany. Iris Walraven's co-authors include J. Belderbos, Floris J. Pos, Uulke A. van der Heide, Joost Dekker, Giel Nijpels, Marcel Verheij, Berlinda J. de Wit–van der Veen, Else A. Aalbersberg, Amber A. van der Heijden and Petra J. M. Elders and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Iris Walraven

61 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris Walraven Netherlands	18	479	251	203	143	105	67	939
Derek Wilke Canada	15	462 1.0×	250 1.0×	151 0.7×	218 1.5×	45 0.4×	52	923
Heath B. Mackley United States	21	298 0.6×	538 2.1×	106 0.5×	58 0.4×	189 1.8×	59	1.1k
Matthew S. Ning United States	19	608 1.3×	544 2.2×	215 1.1×	171 1.2×	164 1.6×	89	1.4k
Maria Teresa Congedo Italy	15	703 1.5×	301 1.2×	107 0.5×	49 0.3×	66 0.6×	101	1.0k
Jennifer Wilkinson United Kingdom	17	279 0.6×	244 1.0×	350 1.7×	322 2.3×	135 1.3×	38	1.3k
Akram Al‐Ibraheem Jordan	15	371 0.8×	328 1.3×	364 1.8×	19 0.1×	120 1.1×	139	870
Fabio Trippa Italy	15	553 1.2×	236 0.9×	198 1.0×	160 1.1×	93 0.9×	45	949
Andrea Lo Canada	17	232 0.5×	166 0.7×	146 0.7×	93 0.7×	77 0.7×	65	796
A. Hervás Spain	14	503 1.1×	263 1.0×	76 0.4×	146 1.0×	60 0.6×	54	807
Raymond B. Mailhot Vega United States	17	472 1.0×	143 0.6×	199 1.0×	275 1.9×	80 0.8×	102	988

Countries citing papers authored by Iris Walraven

Since Specialization

Citations

This map shows the geographic impact of Iris Walraven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Walraven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Walraven more than expected).

Fields of papers citing papers by Iris Walraven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Walraven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Walraven. The network helps show where Iris Walraven may publish in the future.

Co-authorship network of co-authors of Iris Walraven

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Walraven. A scholar is included among the top collaborators of Iris Walraven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Walraven. Iris Walraven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akkermans, Reinier, Kees van Boven, Iris Walraven, et al.. (2024). Which patients are at risk of developing symptom diagnoses that persist for more than a year in primary care? Development and external validation of a prediction model. Journal of Psychosomatic Research. 184. 111859–111859. 1 indexed citations

Walraven, Iris, Iris M. C. van der Ploeg, Michel W.J.M. Wouters, et al.. (2024). Moving beyond barriers: a mixed-method study to develop evidence-based strategies to improve implementation of PROMs in clinical oncology care. Quality of Life Research. 34(1). 173–188. 2 indexed citations

Walraven, Iris, et al.. (2023). Patients’ Characteristics and General Practitioners’ Management of Patients with Symptom Diagnoses. The Journal of the American Board of Family Medicine. 36(3). 477–492. 9 indexed citations

Feldman, Erica, Floris J. Pos, Robert Jan Smeenk, et al.. (2023). Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure. ESMO Open. 8(1). 100775–100775. 7 indexed citations

Bronkhorst, Ewald M., Leontien C.M. Kremer, Eline van Dulmen‐den Broeder, et al.. (2023). Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS‐LATER study. Cancer. 130(6). 995–1004. 1 indexed citations

Hurk, Corina van den, Neil K. Aaronson, J. Belderbos, et al.. (2023). Patient-reported symptom monitoring linked to an alert algorithm: Effects on progression-free and overall survival in the SYMPRO-Lung trial.. Journal of Clinical Oncology. 41(16_suppl). 12099–12099.

Walraven, Iris, Erica A. Wilthagen, Sanne B. Schagen, et al.. (2022). Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracy. Journal of Patient-Reported Outcomes. 6(1). 18–18. 23 indexed citations

Ligt, Kelly M. de, Belle H. de Rooij, Iris Walraven, et al.. (2022). Varying severities of symptoms underline the relevance of personalized follow-up care in breast cancer survivors: latent class cluster analyses in a cross-sectional cohort. Supportive Care in Cancer. 30(10). 7873–7883. 10 indexed citations

Hurk, Corina van den, Floortje Mols, Manuela Eicher, et al.. (2022). A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring. Current Oncology. 29(6). 4370–4385. 26 indexed citations

10.

Belderbos, J., Neil K. Aaronson, Esther Feldman, et al.. (2021). SYMptom monitoring with Patient-Reported Outcomes using a web application among patients with Lung cancer in the Netherlands (SYMPRO-Lung): study protocol for a stepped-wedge randomised controlled trial. BMJ Open. 11(9). e052494–e052494. 10 indexed citations

11.

Walraven, Iris, et al.. (2021). Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study. JMIR Cancer. 7(3). e26574–e26574. 7 indexed citations

12.

Aalbersberg, Else A., Michelle W. J. Versleijen, Margot Tesselaar, et al.. (2020). Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy. Cancer Imaging. 20(1). 57–57. 41 indexed citations

13.

Walraven, Iris, et al.. (2020). Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™). Journal of Patient-Reported Outcomes. 4(1). 81–81. 4 indexed citations

14.

Kwint, Margriet, Cécile Proust‐Lima, Trynke Hoekstra, et al.. (2020). The prognostic value of volumetric changes of the primary tumor measured on Cone Beam-CT during radiotherapy for concurrent chemoradiation in NSCLC patients. Radiotherapy and Oncology. 146. 44–51. 9 indexed citations

15.

Janssen, Tomas, Iris Walraven, Floris J. Pos, et al.. (2020). Knowledge-Based Assessment of Focal Dose Escalation Treatment Plans in Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(4). 1055–1062. 16 indexed citations

16.

Heuvel, Michel M. van den, Erik van Werkhoven, Iris Walraven, et al.. (2019). Local and regional treatment response by 18FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC. Radiotherapy and Oncology. 143. 30–36. 9 indexed citations

17.

Al‐Mamgani, Abrahim, et al.. (2018). Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?. European Archives of Oto-Rhino-Laryngology. 276(2). 575–583. 17 indexed citations

18.

Kwint, Margriet, Iris Walraven, Sjaak Burgers, et al.. (2017). Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases. Lung Cancer. 112. 134–139. 30 indexed citations

19.

Walraven, Iris, Ronald Damhuis, Martijn Geert ten Berge, et al.. (2017). Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium. Clinical Oncology. 29(11). e177–e185. 29 indexed citations

20.

Rauh, Simone P., Femke Rutters, Brian Larsen Thorsted, et al.. (2016). Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study. BMJ Open. 6(9). e012793–e012793. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact